NT 10-K

TAPIMMUNE INC.

Company: Marker Therapeutics, Inc.
Filed: March 31, 2008
Period of Report: December 30, 2007
Accession Number: 0001171520-08-000195

View Document ↗ View on SEC.gov ↗